Home › Market Volatility Leaves Behind Bargain Cancer Biotech - Adaptimmune
 

Keywords :   


Market Volatility Leaves Behind Bargain Cancer Biotech - Adaptimmune

2015-09-10 20:44:16| Biotech - Topix.net

Adaptimmune just hit its all-time low on the NASDAQ after closing just above $11 per share. Since offering shares in early May, the company has traded largely in the $14.50-$15.50 price range.

Tags: market cancer leaves bargain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »